1Practice of incentives for orphan drug research and development in the united states and enlightenment for China:based on the perspective of drug life cycleWU Jing-jing, YUAN Hui-qin, TIAN Meng-yan, LI Guo-dong, MAO Ning-ying2081-20872Progress in the implementation of China's drug conditional approval system and some suggestionsLIU Xuan, LIN Lin, TIAN Li-juan2088-20953Methods of indirect comparison of clinical treatments and case analysisLI Tong-xu, ZHANG Lu-wen, JIA Shuo-peng, HE Han-qing, WANG Xin, TANG Yu, LI Ning, HUANG Hui-yao2096-21014The development trend analysis of glucagon-like peptide-1 receptor agonists from a patent perspectiveLIU Chun-jie, TONG Jing-yi2102-21085Revelutamide,a second-generation androgen receptor antagonist for the treatment of metastatic hormone-sensitive prostate cancerCUI Ying-jie, ZHANG Gui-fang2109-21136Safety evaluation of anti-tumor drugs during early clinical trialsHU Wen-juan, DU Yu, TANG Ling, YANG Zhi-min2114-21187Research progress in cyclin-dependent kinase 9 inhibitorsCAO Zhi-hao, ZENG Yang-jie, LI Wen-xin, ZHANG Rui, WANG Ju-bo, REN Xiao-dong2119-21308Progress in application of organoids technique in new drug evaluationWANG Jun-long, FU Li-xia, WANG Qing-yang, WANG Lei, ZHAO Dan-dan, TIAN Ru, LIU Li, CUI Yi-min2131-21379Research progress in pain management and pharmacological treatment for lumbar facet joint osteoarthritisLIU Chi, SUN Chang-tai, WANG Xiao-bin, QIU Yu-dian, WANG Qiang2138-214210Bioequivalence and safety of lopinavir-ritonavir tablets in healthy Chinese subjectsLIU Tian-mei, DU Xiao-lin, YONG Xiao-lan2143-214811Study on application of new clinical pathology markers in assessment of drug-induced non-clinical gastrointestinal dysfunctionCHEN Tao, ZHANG Yan, LI Hua2149-215212Preparation of chloroquine liposomes and its influence on exosome secretionYAN Lan-lan, YANG Ai, ZHANG Cai, LIU Jie-feng, WANG Xue-li, LU Wei-dong2153-215813Analysis of related substances of mupirocin raw material and ointmentCHONG Xiao-meng, WU Cheng-zhi, CHANG Yi-zhuo, WANG Li-xin, LI Jin, QI Shu-ye, YAO Shang-chen, NING Bao-ming, XU Ming-zhe2159-216814Chemical pattern recognition analysis of flavonoids in Baibu Zhike syrup by HPLC fingerprintYANG Ping, ZHENG Li-hui, LE Lin, TU Qi-jun, WAN Xing, XU Ling, HU Min, FEI Yi-qin2169-217715Data mining and analysis of adverse drug reaction signals for combined serine/threonine-protein kinase B-raf/mitogen-activated protein kinases inhibitors in the U.S.FDA Adverse Event Reporting SystemLIU Hong, WANG Wen-juan, BAI Yu, ZHANG Guan-min, ZHANG Yan-hua2178-218416Analysis of serious adverse drug events in elderly patients using sodium-glucose cotransporter-2 inhibitor based on FAERSYU Hai-yan, SU Wen-ling2185-2192 